title: Development of microglia in the cerebral white matter of the human fetus and infant.
abstract: Although microglial activation may be an initial beneficial response to a variety of insults, prolonged activation can release toxic substances and lead to cell death. Microglial activation secondary to hypoxia-ischemia and/or infection in immature cerebral white matter is important in the pathogenesis of periventricular leukomalacia (PVL), the major pathological substrate of cerebral palsy in the premature infant. We hypothesize that a transient overexpression in activated microglial density occurs normally in the cerebral white matter of the human fetus during the peak window of vulnerability for PVL. Such an increase could render this region susceptible to insults that cause prolonged microglial activation, as conceptualized in PVL. To examine the developmental profile of microglia in the human fetus and infant brain, immunocytochemistry with microglial specific markers were used in 23 control (non-PVL) cases ranging from 20 to 183 postconceptional (PC) weeks. Tomato lectin, used to identify microglial morphology, revealed that the cerebral white matter of the human fetus and infant is densely populated with intermediate and amoeboid microglia; the latter is indicative of an activated state. Quantitative analysis with CD68 showed increased density of activated microglia in the cerebral white matter of the fetus (<37 PC weeks) relative to the neonate/infant (> or =37 PC weeks) and to the overlying cortex of either age group (P = 0.01). The primary finding of a transient, developmental-dependent overabundance of CD68-activated microglia in the cerebral white matter of the fetus suggests a potential "priming" of this area for diverse brain insults characterized by activation of microglia, particularly PVL. J.
authors.affiliation: Department of Pathology, Children's Hospital Boston and Harvard Medical School, MA 02115, USA. saraid.billiard@childrens.harvard.edu
authors.forename: Saraid S
authors.initials: SS
authors.lastname: Billiards
authors.forename: Robin L
authors.initials: RL
authors.lastname: Haynes
authors.forename: Rebecca D
authors.initials: RD
authors.lastname: Folkerth
authors.forename: Felicia L
authors.initials: FL
authors.lastname: Trachtenberg
authors.forename: Lena G
authors.initials: LG
authors.lastname: Liu
authors.forename: Joseph J
authors.initials: JJ
authors.lastname: Volpe
authors.forename: Hannah C
authors.initials: HC
authors.lastname: Kinney
mesh_terms: D000367:Age Factors; D015703:Antigens, CD / Q000378:metabolism; D015214:Antigens, Differentiation, Myelomonocytic / Q000378:metabolism; D002452:Cell Count / Q000379:methods; D002540:Cerebral Cortex / Q000166:cytology* / Q000254:growth & development*; D005333:Fetus; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D007231:Infant, Newborn; D017628:Microglia / Q000502:physiology*; D009687:Nuclear Proteins / Q000378:metabolism; D037121:Plant Lectins / Q000378:metabolism; D015534:Trans-Activators / Q000378:metabolism; D000097382:CD68 Molecule
chemical_list: D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D009687:Nuclear Proteins; D037121:Plant Lectins; D015534:Trans-Activators; C067980:CD68 antigen, human; D000097382:CD68 Molecule; C083728:MHC class II transactivator protein; C034981:tomato lectin